COVID-19: Epidemiological Update for September 22, 2022

Key Points

In Week 37, the spread of SARS-CoV-2 accelerated across the entire mainland, with virological indicators showing a sharp increase.

  • Mainland France:

    • Marked increase in the incidence rate across the entire territory

    • Rise in the incidence rate driven primarily by those under 20 and those aged 30–49 (over 50%)

    • Hospital indicators have stabilized at the national level, with regional disparities

  • Overseas territories:

    • Incidence rates are declining in most regions except Martinique

Variants

  • Omicron sublineages: BA.5 ubiquitous, accounting for 93% of sequences in the Flash S36 survey (09/05)

Prevention

  • Vaccination as of September 19, 2022 (Covid Vaccine data):

    • 74.3% of those aged 18 and older and 82.4% of those aged 65 and older have received their first booster dose

    • 28.7% of those aged 60–79 (34.2% of those eligible based on the time since their last dose) and 36.4% of those aged 80 and older (47.8% of those eligible) have received their second booster dose

  • Given the accelerating spread of SARS-CoV-2, adherence to combined measures remains necessary:

    • up-to-date COVID-19 vaccination, particularly the second booster dose for vulnerable individuals;

    • isolation in the event of a positive COVID-19 test and/or symptoms;

    • continued adherence to preventive measures, including mask-wearing—particularly around at-risk individuals or in crowded indoor settings (such as public transportation or large gatherings)—as well as handwashing and ventilation of enclosed spaces.

In relation to

Our latest news

Appel à candidatures d'experts pour le remplacement d’un membre « sage-femme » du Comité national d'experts sur la mortalité maternelle (CNEMM)

news

Call for Nominations to Fill Vacancies on the National Reference Centers...

news

Public Health France Conference: November 9, 2026

news

Shamonda Virus: First Human Case Detected in France—What Do We Know?